Daily FNArena News - Small Caps
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure ChestPrevious Stories
Dicker Data: Synergies, Costs & Distribution
Jun 06 2023
Recent research on Dicker Data notes an improving distribution capability and potential synergies from recent acquisitions
Dr Boreham’s Crucible: Chimeric Therapeutics
May 26 2023
Tim Boreham reports cancer treatment biotech Chimeric has struggled, but may yet have a sting in its tail
Numbers Are Adding Up For Life360
May 23 2023
Brokers remain enthusiastic on the outlook for Life360 following first quarter results
Nickel Industries: Potential & Risks
May 18 2023
Strong demand projections for nickel have put ASX-listed Nickel Industries on investors’ radar, but the company’s outlook is not risk-free
Avita Medical Preps For Enlarged US Opportunity
May 17 2023
Brokers review first quarter results and pending regulatory approvals for Avita Medical
Judo Capital Offers Differentation
May 11 2023
Brokers continue to rate Judo Capital highly despite looming macroeconomic headwinds
Dr Boreham’s Crucible: Impedimed
May 08 2023
Tim Boreham reports a change in CEO has given cancer monitoring biotech Impedimed a new lease of life
Artificial Intelligence On The ASX
May 02 2023
The ASX-listed AI sector can be split between tech providers developing AI tools and non-tech companies using AI to improve their existing business
Dr Boreham’s Crucible: Volpara Health Technologies
Apr 26 2023
Volpara Health Technologies is revolutionising breast cancer detection. Tim Boreham investigates
Dr Boreham’s Crucible: Radiopharm Theronostics
Apr 13 2023
Cancer detection biotech Radiopharm Theronostics is planning to list on the Nasdaq, and not without good reason, Tim Boreham explains
